The Pharmaceuticals and Medical Devices Agency (PMDA) has added a new project team titled “Project team for Consideration of Guiding Principles for AI Utilization.” This team is part of the agency’s “Projects Across Multi‑Offices” program and will focus on developing guiding principles for the use of artificial intelligence in pharmaceutical and medical device contexts.
Actualités réglementaires24 août 2026•1 min de lecture
PMDA Adds Project Team for AI Utilization Guiding Principles
The Pharmaceuticals and Medical Devices Agency (PMDA) announced a new project team to develop guiding principles for AI utilization, listed under its “Projects Across Multi‑Offices” initiative.
Compilé par l'équipe PharmaCountry · Source : Pharmaceuticals and Medical Devices Agency
Évaluations
(0)
(0)
(0)
(0)
(0)
Plus d'articles
Voir tous les articlesRecherches & Rapports
Global Finished Dosage Manufacturing Landscape 2026
5 oct. 2026
Actualités réglementairesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept. 2026
Laissez votre note